Trial Profile
Efficacy and Safety of a Novel Intradermal Live-attenuated Varicella Zoster Vaccine in Hematopoietic Stem Cell Transplantation Donors: a Randomized Double Blind Placebo-controlled Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 30 Oct 2019
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Varicella zoster virus vaccine live (Primary) ; Imiquimod
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Acronyms VZIDST
- 21 Oct 2019 Status changed from recruiting to completed.
- 27 Jul 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Mar 2018.
- 02 Dec 2015 Planned number of patients changed from 120 to 160, as reported by ClinicalTrials.gov.